chrisvoncsefalvay/vaers-outcomes huggingface dataset:
40 min after Pfizer vaccine, pt c/o CP, tightness VS WNL - 117/76-102-97%. Dr notified, NP in to see, orders to give epi pen received and given by NP @ 1105, medic called, assessed by NP, no diaphoretic episodes noted, 10 min after epi pt. still c/o CP (constant) Patient seen after experiencing SOB and chest pain following Pfizer vaccine. 14 yr old female. Mom denies history of Asthma or any co-morbidities. Interpreter communicated with mother and child. Mother stated child was not anxious about receiving vaccine. Child also states the same. Approx 40 min after receiving vaccine child begin to experience chest pain and SOB. Upon assessment vital signs were stable  Patient c/o chest tightness, SOB, and feeling weak. When asked if chest pain felt like heaviness as if something was sitting on the chest her response was yes. No radiation to other parts, no nausea. Chest was constant Dr was called. Orders was given for epi Epinephrine 0.3mg via auto injector was administered by NP. Medic was called Patient remained complains of chest pain, vital WNL. Patient taken to hospital via ambulance.
Feverish, Body Aches, Arm aches, Sleepiness, Fatigue
Clinic accidently administered the Moderna COVID-19 vaccine to a 14  year old patient for their initial dose of their primary series on 21APR2022.  Due to the patient's age (under 18 years) they were not eligible to receive this type of COVID-19 vaccine per CDC and Agency guidelines.  This vaccination error was discovered on 01JUN2022 by immunizations team when the mother of patient came into to get the second dose shot of the their primary series.  The mother of the patient was informed about the error and a Agency and VAERS report submitted.  The Agency was contacted on 01JUN2022 to get further guidance and recommendations.  The mother of the patient stated that her 14  year old daughter did not experience any adverse reactions to the initial Moderna COVID-19 vaccination that was administered on 21APR2022.
Pt reports soon after receiving injection she experienced HA, nausea and general malaise. She returned to the physician's office on 7-19-2012 and it was noted that she had reacted locally to the first injection and should discontinue any additional injections. I did not give injection and was made aware of the issue today with the GARDASIL. Wanted to ensure all paperwork was on file for this pt even though.
Client is fully vaccinated using Pfizer vaccine.  Last dose on 3/25/2021.  Tested positive for COVID -19 on 6/2/2021.  Symptoms included:  cough, shortness of breath, fatigue, headache, and runny nose.  Vaccine given at hospital
sore arm at injection site; headache; fatigue; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Dec2021 13:15 (Lot number: fh8027) at the age of 47 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Time of administration: 13:00, Anatomical location: Arm Left, Batch/Lot No: ep6955), administration date: 31Mar2021, when the patient was 46 years old, for COVID-19 Immunization, reaction(s): "muscle aches", "chills"; Bnt162b2 (Dose Number: 1, Batch/Lot No: el3247), administration date: 10Mar2021, when the patient was 46 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 13Dec2021 13:15, outcome "unknown", described as "booster"; VACCINATION SITE PAIN (non-serious) with onset 14Dec2021 06:30, outcome "recovering", described as "sore arm at injection site"; HEADACHE (non-serious) with onset 14Dec2021 06:30, outcome "recovering", described as "headache"; FATIGUE (non-serious) with onset 14Dec2021 06:30, outcome "recovering", described as "fatigue". Therapeutic measures were not taken as a result of vaccination site pain, headache, fatigue.  Additional information: Facility where the most recent COVID-19 vaccine was administered was noted as workplace clinic. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with covid-19 and since the vaccination, the patient had not been tested for covid-19. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine and list of any other medications, the patient received within 2 weeks of vaccination was noted as no.  Follow-up attempts are completed. No further information is expected.
he fainted and passed out for 1 minute as soon as I administered the J&J vaccine to him i laid him on the floor , he regained his consciousness after 2 minutes  the EMT  came in and handled the situation . he felt okay after 15 minutes
Pt turned white & limp & non responsive for a few minutes then started screaming & crying non stop t102; This AM temp but otherwise OK;
aches over entire body by 11pm couldn't sleep, stuffy congestion in upper head including blocked ears by 5am, severe migraine headache by 7am and wouldn't ease up to half the pain til following day, chills during night and  sweating during day, severe dizziness when moving head down with nausea when did that, otherwise no nausea - no fever or other covid symptoms and felt fine that day.   I wear Oura ring which indicated I was well that day, next day it dropped in half indicating immune system was struggling, next day it's come up some to say need more rest.  Took advil, tramadol, mucinex dm, and relpax at separate times in effort to find relief.  Today (2 days afterwards) taking mucinex and relpax and feel about 50% better.  Never had a reaction to flu shot before.
severe reactogenicity; day off work.; This case was reported by a other health professional via sales rep and described the occurrence of reactogenicity event in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced reactogenicity event and inability to work. On an unknown date, the outcome of the reactogenicity event and inability to work were unknown.   It was unknown if the reporter considered the reactogenicity event and inability to work to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, after vacination with 2nd dose of Shingrix, the patient experienced severe reactogenicity and required to take the day off work. The patient did not experienced any adverse event after 1st dose of Shingrix. No additional information provided.
Symptoms started when waking up on Monday 6/14; headache, muscle ache, joint pain, tiredness, sore arm; started taking Ibuprofen throughout the day.  Tuesday 6/15 experienced fever, chills, still aches and pains, headache.
Woke up at 3pm the following day burping the taste of boiled eggs. No boiled eggs had been eaten and still burping the boiled egg taste at 10pm.
Large red rash around vaccination site noticed day after vaccine.  Applied cortisone cream on second day and is currently improving.
Pt recvd 3rd hep B vax & devel hepatitis p/3rd dose given 30APR90 w/Recombivax; Brand(s) used for 1st & 2nd doses unspecified; Hepatitis resolved 02MAY90;
A psychologist reported that one of his parents received an injection of Flu Shield (2001-2002 formula) in 2001. Approximately 10 days post-immunization, the patient became very ill. The reporter stated that his patient "lost nerves in the left leg and has lost complete use of the left leg". The reporter indicated that his patient has recovered to some degree. The reporter declined to provide additional information. This event was considered medically important (OMIC).
today a child received an expired Daptacel vaccine, with no reported adverse event; Initial information was received on 23-Jun-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves Child male patient who reported that today a child received an expired diphtheria-15/tetanus/5 ac pertussis vaccine (daptacel) with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included hepatitis b vaccine for Prophylactic vaccination.  On 23-Jun-2023, the patient received a dose of 0.5 ml of suspect diphtheria-15/tetanus/5 ac pertussis vaccine (strength, expiry date reported) (lot C5893AA) via intramuscular route in unknown administration site for Immunization.  On 23-Jun-2023 the patient developed a non-serious event of today a child received an expired daptacel vaccine, with no reported adverse event (expired product administered) (latency : same day) following the administration of diphtheria-15/tetanus/5 ac pertussis vaccine.  Action taken with DIPHTHERIA, TETANUS and acellular pertussis vaccine (Daptacel) was not applicable.  At time of reporting, the outcome was Unknown for the event today a child received an expired daptacel vaccine, with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Headache; muscle pain; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced headache and muscle pain. On an unknown date, the outcome of the headache and muscle pain were not recovered/not resolved.   It was unknown if the reporter considered the headache and muscle pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as an adult as per vaccine indication.  The patient received Shingrix vaccine and had headache and muscle pain. The reporter inquired how long did headache and muscle pain lasted after receiving vaccine for shingles.
Twinrix expired dose administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 42-year-old female patient who received HAB (Twinrix) (batch number P9LT9, expiry date 01-JAN-2023) for prophylaxis.   On 06-MAR-2023, the patient received the 1st dose of Twinrix. On 06-MAR-2023, an unknown time after receiving Twinrix, the patient experienced expired vaccine used (Verbatim: Twinrix expired dose administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 08-Mar-2023 On 8th March 2023, a pharmacist called to inform that a patient was administered a dose of Twinrix on 6th March 2023, but such dose had already expired on 1st January 2023. The reporter consented to follow up.  The Vaccine Administration Facility was the same as Primary Reporter. The patient received vaccine, which was already expired on 1st January 2023, which led to expired dose administered.
Hearing loss. Feels like pressure in ears. Like they need to pop. Noticed I can?t hear as well when in the car listening to radio.
dizziness; burning tongue, mouth, and lips; burning tongue, mouth, and lips; sinus pressure; no ability to smell or taste; no ability to smell or taste; bitter taste; sense of being poisoned or given some horrible drug; temperature went up to 98.9; EXTREME fatigue; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL1283), via an unspecified route of administration on 22Jan2021 10:45 at single dose on left arm for covid-19 immunisation. Medical history included known allergies: sulfa, hypo thyroid, hypogammaglobulinemia, arthritis and hypertension. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included losartan, carvedilol, methylphenidate hydrochloride (RITALIN), potassium and unspecific thyroid medication. It was reported that second day after vaccination (24Jan2021), patient experienced extreme fatigue. Third day after vaccination (25Jan2021) patient experienced extreme fatigue, dizziness, burning tongue, mouth, and lips, sinus pressure, no ability to smell or taste except a bitter taste, sense of being poisoned or given some horrible drug, temperature went up to 98.9 - which is high for patient. Patient was usually 97.2. On fourth day of vaccination (26Jan2021): patient was fine. Totally back to normal. No treatment was received. The events resulted doctor or other healthcare professional office/clinic visit. This case was reported as non-serious. All events were resolved on 26Jan2021.
extreme fatigue, extreme low back pain I also don't know which flu vaccine I received I just picked the first one listed
Chills, Fever, Fatigue, and JOINT PAIN... which continues two weeks later
My left arm was sore at injection site for 2 days after the first dose. Then it went away. Yesterday, 7 days after the first shot, I have a rash that is warm, swollen, and growing on my left arm. It is not at the exact injection site, but on the same upper arm area. Yesterday it was small, about the size of a quarter, then last night it was bigger, about the 2 inches. This morning at 7am it was about 4 inches, and now at 4:00pm  it is about 5.5 inches.
doses administered after excursion; No adverse event; Patient administered doses of the vaccine after excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient administered doses of the vaccine after excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) in a 47-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 04-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 04-Nov-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient administered doses of the vaccine after excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient administered doses of the vaccine after excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patient administered doses of the vaccine after excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion).    No Concomitant medications were provided. Reporter reported that a temperature excursion that occurred several days ago in the Freezer.  Multiple patients received vaccine from vaccine that underwent a temperature excursion in the Freezer.  Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable 131 patients received doses of the vaccine in question. Patient did not report any adverse event.  No treatment medications were provided.
Fainting, total of 3 times. Last time of fainting was 2 days after the booster. Unfortunately did not document the date on the first two fainting episodes, because it did not happen right away. I was not associating it with the vacine.  I have not gotten any additional vaccine for fear of fainting. I live alone.  Have not had any previous fainting episodes , nor any additional sine the last.  Don't know what to do. Primary says she cannot tell me, it's up to me. I asked the pharmacist, he said if I don't have any other risks (just my age) he would not push it.
Began with intermittent painful spot on right side of neck.  On 10/07/2022 pain spread to area from top on head to chest on the right side and swelling of thyroid. Fatigue, pulse sometimes over 100, irregular heartbeat, need to eat at least 4 times /day, small weight loss. Was mailed order for thyroid ultrascan which was performed 10/18/2022, blood test on 10/19/2022 at which point thyroiditis was diagnosed and I was told to stop taking Synthroid.  From online publications I have read that this is "self-limiting" but I am beginning to wonder whose limits will be reached first. Thankfully the pain has subsided but not gone away.
I have the COVID symptoms; Like I have the COVID; Fever; Breaking fever; Chills; Body Ache; I don't feel good right now; I feel like I want throw up; My arm is swollen; and my arm is swollen at the site; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 47-year-old female patient received first dose of bnt162b2 (Pfizer covid-19 vaccine, Solution for injection, Batch/lot number: Unknown, Expiry date: Unknown), via an unspecified route on 11Aug2021 (age at vaccination: 47-year-old), as a single dose for covid-19 immunization. Medical history included type 2 Diabetes, vitamin D deficiency and cholesterol. Concomitant medications included Vitamin D because she is vitamin D deficient, she took most of Vitamins, statins for cholesterol and she takes regular medicine/every day. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 12Aug2021, patient started having fever, breaking fever, started having Chills, body ache. Patient did the Pfizer the first shot experienced covid symptoms because she was having fever, chills; on an unspecified date in Aug2021, her arm was swollen at the site, like she has the covid, she doesn't feel good right now. She felt like she wants to throw up. Patient will go back in three weeks for the second dose. Therapeutic measures taken as a result of the events included Tylenol for fever. The clinical outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt has 6.5 inch by 6.0 inch induration with erythema. No regional Lymphadenopathy.
I have had neuropathy pain  in feet for two years.  It has never changed during that time. I had my Pfizer vaccine on April 28. Within a couple of days, I had shooting pains up my feet, legs, and into my arms. It has continued to progress, and now I have constant  shooting pains, shocking nerve pains, and burning throughout my feet, legs, hips, back, arms and hands.
Headache Vomiting Unable to hold food or water Fever Chills Nausea
On 6/12/01, the vaccinee received his 5th 0.5cc IM dose of Infanrix, his 4th 0.5cc SC dose of IPOL and his 2nd 0.5cc SC dose of MMR. On 6/13/01, he experienced injection site redness with 3" swelling, warm to touch and "low-grade" tenderness (per pt). Ibuprofen 1 1/2 teaspoons orally every 6 hours as needed was administered from 6/13/01 to 6/14/01 for swelling and discomfort as well as cold packs to the site. Redness and swelling subsided after 2-3 days with no compromising effects thereafter. Infanrix was discontinued. The reporter stated that the adverse evens were moderate in severity and were related to Infanrix. As of 8/15/01, the adverse events had resolved.
Because of flu-like symptoms after 1st Shingrix, I took 400 mg Ibuprofen 2 hrs before this 2nd vaccination (per MD). 14 hrs after vaccine, had onset of flu-like symptoms same as before: headache, fever up to 100.8, SEVERE chills (worse than with first vaccination), muscle aches. Took Ibuprofen q 12 hrs per MD and symptoms only lasted about 2 days instead of 3 days.  Injection site was sore but not nearly as swollen and inflamed as first time.  (Filed separate VAERS Report about reaction to 1st vaccination).  PLEASE NOTE: Pharmacy records state 2nd Shingrix was given on August 7, 2020.  It was NOT.  It was definitely given to me on August 10, 2020.
This spontaneous report as received from a physician refers to a 1 year old patient of unknown gender. On 27-FEB-2014, the patient was subcutaneously vaccinated with dose of MMR II, HSA, 0.5 ml (lot#, expiration date, anatomical location were not reported). On 10-JUN-2014, the patient was subcutaneously vaccinated with dose of MMR II, HSA, 0.5 ml (lot#, expiration date, anatomical location were not reported). No adverse experience was reported. Additional information has been requested.
Vaccine was give 3 hours and 12 minutes after vial was punctured and left at room temperature. Per Janssen, there are no updates on stability beyond the 2 hours at room temperature. Patient has not reported any adverse events as a result of this event.
I received the flu shot yesterday, fluarix quad, I got redness, pain, swelling at the shot area and mild fever. I also feel very tired.
Right deltoid became red, hot, swollen, painful.  Urticaria, red streak from local reaction under arm.  Very itchy. Fever max.101.6 for 3 days. Tachycardia from 100-130 for three days
Patient called the pharmacy 2 days after SHINGRIX was administered and reported that, starting the evening she received the injection, she had a 2-day history of feeling dizzy with a fever. She also reported that her arm was red, swollen, and felt hot to the touch. She reported no trouble breathing, facial swelling, or life-threatening symptoms. She was advised to monitor symptoms at home and make a doctor's appointment if they did not subside within a few days, or to seek emergency medical attention if life-threatening symptoms developed.
both legs hurt, bruised. R thigh red hot, bruise size of quarter, hot to touch. Tylenol, ice to area, alcohol.
1. 14hrs after injection for 3 days: fever, muscle ache, chill, headache, dizzy  2. One week: Headache and dizzy  3. 6 weeks: felt tired  4. 5/14: started headache and muscle ache again 5. 5/17: went to healthcare facility and diagnosed with shingles  6. Up today (6/11) still in slowing recovery process
This spontaneous report was received from a registered nurse referring to unspecified patients of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions or concomitant medications. Since 14-JUN-2017, the patients were vaccinated with RECOMBIVAX HB lot # N002202 with expiration date on 11-APR-2019 and lot # N002913 with expiration date on 23-FEB-2019, 0.5 ml, intramuscularly for prophylaxis. The doses of RECOMBIVAX HB were exposed to a temperature excursion of 32 degrees Fahrenheit (°F) during a time frame of 2 minutes which was detected by the data logger. Previous temperature excursion was reported as of 30 °F for 6 minutes and no adverse events were reported.
I had my shot at 4:00 PM on March 17th.  I woke up about 11:00 PM with a bad headache, chills, fever.   I had no appetite, was tired and my head felt foggy.  The next morning I started breaking out with hives on my forehead, neck, upper back and chest.   I had chills and fever again the next day.  My hives finally started to subside on Sunday the 21st.